Treatment for Gout Flare-Up
For acute gout flares, first-line treatment options include colchicine (within 12 hours of symptom onset), NSAIDs, or oral corticosteroids, with the choice based on patient factors and timing of treatment. 1, 2
First-Line Treatment Options
Colchicine
- Most effective when given within 12 hours of symptom onset 1, 2
- Recommended dosing: 1 mg loading dose followed 1 hour later by 0.5 mg on day 1 1, 3
- Contraindications:
NSAIDs
- Can be used as monotherapy or in combination with colchicine for severe flares 1
- Should be avoided in patients with:
- Severe renal impairment
- History of peptic ulcer disease
- Uncontrolled hypertension
- Heart failure 4
- Short-acting NSAIDs (diclofenac, ketoprofen) are preferred in elderly patients 4
Oral Corticosteroids
- Prednisolone 30-35 mg daily for 3-5 days 1, 2
- Alternative regimen: 0.5 mg/kg/day for 5-10 days at full dose then stop, or 2-5 days at full dose followed by a 7-10 day taper 2
- Particularly useful in patients with contraindications to colchicine or NSAIDs 2
- Monitor blood glucose in diabetic patients 2
Treatment Selection Algorithm
If symptoms started <12 hours ago:
If symptoms started >12 hours ago:
- NSAIDs or oral corticosteroids are preferred 1
If patient has renal impairment:
If patient has cardiovascular disease:
- Avoid NSAIDs
- Use colchicine (if renal function is normal) or oral corticosteroids 2
For severe or polyarticular flares:
Important Clinical Considerations
- Early treatment is crucial for optimal efficacy 1, 2
- The "pill in the pocket" approach is recommended to allow patients to self-medicate at the first warning symptoms 1
- Continue treatment until the flare completely resolves 2
- Underdosing may lead to incomplete resolution of symptoms 2
- When initiating urate-lowering therapy (ULT), prophylactic anti-inflammatory therapy should be used for 3-6 months to prevent flares 1, 2, 5
Common Pitfalls to Avoid
- Delaying treatment beyond 12-36 hours, which significantly decreases efficacy 2
- Using colchicine in patients with severe renal impairment 1, 3
- Using NSAIDs in elderly patients with comorbidities 4
- Failing to provide prophylaxis when initiating urate-lowering therapy 1, 5
- Treating pain only without addressing the underlying inflammatory process 3
- Extended use of steroids beyond the recommended duration, increasing risk of adverse effects 2
Following these evidence-based recommendations will help effectively manage gout flares while minimizing adverse effects and improving patient outcomes.